尤物视频污,99热99热99超碰,精品久久久久女少妇,少妇精品无码,日B视屏久久香色,亚洲美女午夜福利av,国产美女被操,国产九九精品,国产久久色情

Shandong Boyuan Pharmaceutical Co., Ltd. is a high-tech enterprise specializing in the research, production, and sales of pharmaceutical intermediates and active pharmaceutical ingredients (APIs). The company, formerly known as "Shandong Boyuan Chemical Co., Ltd.," was established in September 2005 and obtained its drug production license in January 2012. The company is located in the Jibei Economic Development Zone of Jinan City, covering a site area of 30,000 square meters. It has constructed multiple API and synthesis workshops that comply with GMP standards, complete with supporting utilities and auxiliary facilities. The company has established a stringent quality management system and quality standards aligned with international practices, along with advanced quality control methods.

Since its inception, the company has consistently adhered to an innovation-driven development strategy, focusing on building its technological innovation capabilities. The research and development of new products closely follow international trends in new drug development, gradually forming a product system of APIs and pharmaceutical intermediates in areas such as anti-tumor, anti-fungal, analgesic-anesthetic, and hypoglycemic agents. The company currently holds multiple invention patents with independent intellectual property rights. It was recognized as a high-tech enterprise in 2010, designated as an "intellectual property pilot enterprise" by the Jinan Intellectual Property Office in 2011, and its technology R&D center was accredited as a municipal engineering technology center by the Jinan Science and Technology Bureau.

Upholding the philosophy of "quality first, service supreme," the company always prioritizes the interests of its customers. Through meticulous service, it provides high-quality products to its clients. The company's products are now exported to markets in Europe, America, Japan, South Korea, India, and others. Domestically, it has become a supplier of APIs for major pharmaceutical companies such as Yangtze River Pharmaceutical, Hengrui Medicine, Simcere, and Neptune.

Looking toward the future, the company will embrace the spirit of "continuous innovation, determined exploration, respect for science, and respect for talent" to maintain sustained technological innovation capabilities. Guided by the business philosophy of "integrity, pragmatism, innovation, and development," it will provide customers with high-quality products and optimal services.